Found 0 matching trials
CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
PHASE3The purpose of this study is to evaluate the clinical efficacy of blisibimo...
Location
Multiple Locations
Curcumin in Management of Chronic Obstructive Pulmonary Disease
NAIn this double-blind, placebo-controlled trial, 120 patients with a diagnos...
Location
Pulmonary and Sleep Medicine clinic
Improving the Results of Heart Bypass Surgery Using New Approaches to Surgery and Medication
NASurgery for blocked arteries in the heart (coronary artery bypass grafting)...
Location
Sunnybrook Health Sciences Centre
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647
PHASE1The main objective of this study is to evaluate the safety, reactogenicity,...
Location
Velocity Clinical Research
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets
PHASE1To Evaluate the Safety, Tolerability and Pharmacokinetics of GST-HG131 Tabl...
Location
The first hospital of Jilin University
Effect of Aerobics and Balancing Exercises on Anxiety and Dizziness in Patients With COVID-19
NAThe recently emerged coronavirus named Severe Acute Respiratory Syndrome Co...
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NAElevated plasma triglycerides (TG) are due to an excess of TG-rich lipoprot...
Location
University of Arizona
A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
PHASE2A Dose-Ranging Study of the Efficacy of ABT-894 in Adults with Attention-De...
Location
Site Reference ID/Investigator# 5965
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults
PHASE1The purpose of this study is to assess safety, tolerability, preliminary ef...
Location
Multiple Locations
Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia
NAPurpose: Tardive dyskinesia (TD) is a involuntary movement disorder that ca...
Location
University of North Carolina at Chapel Hill